TSH Biopharm Corporation Limited (8432.TWO)
TWD 60.7
(-2.72%)
TWD 60.7
(-2.72%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 810.91 Million | 741.06 Million | 413.48 Million | 447.86 Million | 507.66 Million |
| Cost of Revenue | 411.01 Million | 351.19 Million | 166.12 Million | 162.67 Million | 202.54 Million |
| Gross Profit | 399.89 Million | 389.87 Million | 247.35 Million | 285.19 Million | 305.11 Million |
| Operating Expenses | 336.26 Million | 320.8 Million | 191.84 Million | 210.99 Million | 248.92 Million |
| Selling, General and Administrative Expenses | 311.45 Million | 289.71 Million | 168.32 Million | 182.31 Million | 197.12 Million |
| Research and Development Expenses | 24.81 Million | 31.09 Million | 23.51 Million | 28.68 Million | 51.79 Million |
| Other Expenses | - | 12.58 Million | 3.91 Million | 717 Thousand | - |
| Cost and Expenses | 747.28 Million | 672 Million | 357.96 Million | 373.66 Million | 451.46 Million |
| Operating Income | 63.63 Million | 84.97 Million | 61.52 Million | 77.15 Million | 56.19 Million |
| Interest Expense | 688 Thousand | 699 Thousand | 80 Thousand | 27 Thousand | 82 Thousand |
| Income Tax Expense | 11.11 Million | 15.09 Million | 14.44 Million | 15.66 Million | 18.02 Million |
| Earnings before Tax | 76.09 Million | 81.24 Million | 61.54 Million | 77.23 Million | 103.35 Million |
| Net Income | 61.98 Million | 61.89 Million | 47.1 Million | 61.57 Million | 85.32 Million |
| Earnings Per Share Basic | 1.61 | 1.61 | 1.23 | 1.60 | 2.22 |
| Earnings Per Share Diluted | 1.61 | 1.61 | 1.23 | 1.60 | 2.22 |
| Weighted Average Shares Outstanding | 38.39 Million | 38.39 Million | 38.29 Million | 38.39 Million | 38.39 Million |
| Weighted Average Shares Outstanding (Diluted) | 38.43 Million | 38.45 Million | 38.29 Million | 38.43 Million | 38.43 Million |
| Gross Margin | 0.49 | 0.53 | 0.60 | 0.64 | 0.60 |
| EBIT Margin | 0.12 | 0.14 | 0.17 | 0.19 | 0.22 |
| Profit Margin | 0.08 | 0.08 | 0.11 | 0.14 | 0.17 |
| EBITDA | 99.35 Million | 106.5 Million | 71.31 Million | 86.8 Million | 113.04 Million |
| Earnings Before Tax Margin | 0.08 | 0.11 | 0.15 | 0.17 | 0.11 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 235.58 Million | 200.49 Million | 443.04 Million | 810.91 Million | 123.7 Million | 126.7 Million |
| Cost of Revenue | 111.02 Million | 76.19 Million | 256.1 Million | 411.01 Million | 53.11 Million | 52.74 Million |
| Gross Profit | 124.56 Million | 124.29 Million | 186.93 Million | 399.89 Million | 70.59 Million | 73.95 Million |
| Operating Expenses | 99.86 Million | 80.09 Million | 172.46 Million | 338.2 Million | 57.02 Million | 53.64 Million |
| Selling, General and Administrative Expenses | 94.12 Million | 70.76 Million | 164.5 Million | - | 52.34 Million | 48.78 Million |
| Research and Development Expenses | 5.73 Million | 9.32 Million | 7.96 Million | - | 4.68 Million | 4.85 Million |
| Other Expenses | 193 Thousand | 694 Thousand | -244 Thousand | 6.54 Million | 7.09 Million | 265 Thousand |
| Cost and Expenses | 210.89 Million | 156.28 Million | 428.57 Million | 749.22 Million | 110.14 Million | 106.38 Million |
| Operating Income | 26.64 Million | 45.52 Million | 16.23 Million | 74.84 Million | 21.61 Million | 23.04 Million |
| Interest Expense | 120 Thousand | 26 Thousand | 597 Thousand | 688 Thousand | 26 Thousand | 30 Thousand |
| Income Tax Expense | 9.91 Million | 10.56 Million | -1.55 Million | 11.11 Million | 4.72 Million | 4.8 Million |
| Earnings before Tax | 25.7 Million | 45.53 Million | 17.63 Million | 76.09 Million | 21.55 Million | 23.08 Million |
| Net Income | 14.01 Million | 40.92 Million | 16.19 Million | 61.98 Million | 16.83 Million | 18.27 Million |
| Earnings Per Share Basic | 0.37 | 1.07 | 0.42 | - | 0.44 | 0.48 |
| Earnings Per Share Diluted | 0.36 | 1.06 | 0.42 | - | 0.44 | 0.48 |
| Weighted Average Shares Outstanding | 37.88 Million | 38.39 Million | 38.33 Million | 38.39 Million | 38.26 Million | 38.07 Million |
| Weighted Average Shares Outstanding (Diluted) | 38.93 Million | 38.43 Million | 38.35 Million | 38.43 Million | 38.26 Million | 38.07 Million |
| Gross Margin | 0.53 | 0.62 | 0.42 | 0.49 | 0.57 | 0.58 |
| EBIT Margin | 0.15 | 0.26 | 0.07 | - | 0.20 | 0.18 |
| Profit Margin | 0.06 | 0.20 | 0.04 | 0.08 | 0.14 | 0.14 |
| EBITDA | 34.67 Million | 51.26 Million | 30.09 Million | - | 24.26 Million | 23.2 Million |
| Earnings Before Tax Margin | 0.11 | 0.23 | 0.04 | 0.09 | 0.17 | 0.18 |
BIOG
EEGUF
MTO
3422
5230
BBY